NSEInvestor Presentation4d ago · 31 Jul 2026, 06:50 pm

Investor Presentation

Yasho Industries Limited · YASHO

✦ AI SummaryResults

Yasho Industries Limited has informed the Exchange about Investor Presentation for Q1FY27, which has been uploaded on the Company's website.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Yasho Industries Limited has informed the Exchange about Investor Presentation

Attachments (1)

📄

8291904474_31072026184640_Investor_Presentation_Q1FY27.pdf

pdf

Download →
View document text
Date: July 31, 2026 To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, G Block, Dalal Street, Fort, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 001. Mumbai – 400 051. Scrip Code: 541167 Symbol: YASHO Dear Sir/ Madam, Sub: Investor Presentation- Q1FY27 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a copy of the Investor’s Presentation for Q1FY27 is enclosed herewith, and the said Investor’s Presentation has also been uploaded on the Company’s website at www.yashoindustries.com We request you to kindly take the same on record. Thanking You, For Yasho Industries Limited Rupali Verma (Company Secretary & Compliance Officer) Membership No. A42923 Encl: As above YASHO INDUSTRIES LIMITED REGISTERED OFFICE: Office No. 101/102, Peninsula Heights, C.D Barfiwala Marg, Juhu lane, Andheri (West), Mumbai – 400058, India TEL: +91 22 62510100; FAX: +91 22 62510199; E-Mail: info@yashoindustries.com; CIN No: L74110MH1985PLC037900 INVESTOR PRESENTATION Q1 FY2027 Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Yasho Industries Limited (the “Company”), have been prepared solely for information purposesand do not constitute any offer, recommendationor invitation to purchaseor subscribe for any securities, andshallnotformthe basisorbereliedoninconnectionwithanycontractorbindingcommitmentwhatsoever.Noofferingofsecuritiesofthe Company willbemadeexceptbymeansofastatutoryofferingdocumentcontaining detailedinformationabouttheCompany. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may considermaterial.Anyliabilityinrespectofthecontentsof,oranyomissionfrom,thisPresentationisexpresslyexcluded. Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its exposure to market risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and theCompanyisnotresponsibleforsuchthirdpartystatementsandprojections. COMPANY OVERVIEW About Us 2 140+ Leading Specialty Chemicals Company Business Categories Total Products Incorporated in 1985 by Jhaveri Family and started its manufacturing operations in 1993, Yasho Industries Limited (YIL) is a specialty chemicals manufacturer engaged in producing high-performance ingredients used 1 50+ across industrial and consumer applications, including lubricant additives and rubber chemicals R & D Facility In-House Researchers The company combines expertise in complex chemistry with a strong focus on product innovation and process efficiency, enabling it to develop a diversified portfolio of value-added products. 830+ Employees Global Subsidiary With integrated manufacturing capabilities and continuous investment in R&D, Yasho is steadily moving up the value chain while catering to leading global multinational corporations (MNCs), positioning itself as a scalable and innovation-driven player in the specialty chemicals space. 50+ 40+ Global footprint across Years of Excellence Countries Board of Directors Mr. Vinod Jhaveri Mr. Parag Jhaveri Mr. YayeshJhaveri Chairman & Executive Director Managing Director & CEO Whole Time Director Mr. Anurag Surana Mr. U R Bhat Dr. Prakash Bhate Mrs. Sudha Navandar Non-Executive Independent Director Non-Executive Independent Director Non-Executive Independent Director Non-Executive Independent Director Diversified product Portfolio ready to capture growing demand Consumer Division Industrial Division Applications Applications • Flavours and fragrances; personal care products -cosmetics & • Tyres, Automobile components, Conveyor belts, surgical gloves, latex toiletries gloves, condoms, balloons • Agrochemicals & Pharmaceutical products • Hydraulic, turbine, engine & gear oils, metal working fluids & greases • Oral care preparations • Stabilisers for acrylics, printing inks/coating, UPR resins and fibre • Edible oil, Confectioneries & food stuff, Animal feed, Vitamin premix, composite resins Nutraceutical Manufacturing plants (1/2) About Pakhajan Plant Pakhajan Plant Spread across 42 acres, the plant features scalable infrastructure capabilities along with an Inhouse Research Facility. Business Rationale Dedicated Plant for working on products which have potential growth in future. Our Edge Present Land utilization is 25% of the land parcel available. Capable of supporting 20-25% growth without additional capex in infrastructure Capex Incurred till date The company incurred capex of ₹18.05 crore on this plant during the current year. Peak Revenue Capacity At optimal utilization, the existing site has the potential to generate peak revenue of ₹800–850 crore. Manufacturing plants (2/2) About Vapi Plant Vapi Facilities The plant comprises versatile manufacturing unit. Business Rationale Multi-functional plant-to create as many different chemistries as required. Our Edge Strategically located near key ports, enabling us to efficiently cater to global customers while maintaining high standards of quality and timely delivery. Peak Revenue Capacity At optimal utilization, the site has the potential to generate peak revenue of₹650-700 crores. Research & Development R&D facilities Number of Inhouse Researchers The company has a strong in-house R&D team comprising more than 50 researchers Area The company operates a dedicated facility spread across 25,000+ sq. ft. Location The company’s in-house R&D facility is located at Pakhajan. BUSINESS UPDATE Management Commentary & Outlook • Business Performance The company maintained its strong growth momentum in Q1 FY27, reporting consolidated revenue of ₹ 307.74 croreand EBITDA of ₹ 74.42 crore, supported by 42% year-on-year volume growth in Q1FY27. This was driven by an additional off-take by existing customers and acquisition of marquee international customers. The company also forayed into Asian and African geographies. This is despite global supply challenges and the middle-east crisis. The increase in margins was achieved by improved product mix, cost efficiencies and operating leverages. The company is also expanding into industrial chemicals, focusing on products with opportunities arising from global demand. • Financial Strength The company’s debt-to-EBITDA ratio improved to1.86x inQ1 FY27, from 3.75x in Q4 FY26. The company remains committed to strengthening its balance sheet. Bank Loan Ratings of the Company [Showing first 8,000 characters — download PDF for full document]